2m 2m 2m 2m 2m 2m 2m
Editas Medicine (EDIT)
NASDAQ
$2.83+$0.05 (+1.62%)
Price as of Jun 03, 2026 7:41 PM EDT- $531.0MMarket Cap
- 52.75%1-Year Change
- BiotechnologyIndustry
Editas Medicine (EDIT)
$2.83+$0.05 (+1.62%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 9.46% | 9.3M | -83,802 (-0.90%) | Mar 31, 2026 |
VANGUARD GROUP INC | 8.38% | 8.2M | +1.2M (+15.14%) | Dec 31, 2025 |
BLACKROCK INC. | 7.95% | 7.8M | -50,264 (-0.65%) | Jun 30, 2024 |
BLACKROCK FUNDING, INC. /DE | 7.46% | 7.3M | -716,636 (-9.81%) | Dec 31, 2024 |
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC | 5.06% | 5.0M | +5.0M (+100.00%) | Jun 30, 2016 |
N/A | 4.29% | 4.2M | +4.2M (+100.00%) | Mar 31, 2026 |
RENAISSANCE TECHNOLOGIES LLC | 4.06% | 4.0M | +932,382 (+23.47%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
TIAA-CREF FUNDS | 1.90% | 1.9M | -31,990 (-1.72%) | Jan 31, 2026 |
SMALLCAP WORLD FUND INC | 1.12% | 1.1M | 0 (0.00%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 0.73% | 712,028 | -105,669 (-14.84%) | Feb 28, 2026 |
VICTORY PORTFOLIOS | 0.59% | 582,500 | 0 (0.00%) | Mar 31, 2026 |
SCHWAB STRATEGIC TRUST | 0.59% | 578,852 | +51,500 (+8.90%) | Feb 28, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.53% | 521,021 | +46,441 (+8.91%) | Feb 28, 2026 |
Ark ETF Trust | 0.52% | 505,580 | 0 (0.00%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions951.2M (77.63%)
- Mutual Funds261.4M (21.33%)
- Insiders12.8M (1.05%)
- Other0 (0.00%)
Insider Transactions
- 1.05% (12.8M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $2.4MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Parison Amy SVP, Chief Financial Officer | Award | Mar 12, 2026 | $0.00 | 292,856 | $0.00 | 292,856 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Award | Mar 12, 2026 | $0.00 | 292,856 | $0.00 | 292,856 |
O'Neill Gilmore Neil CEO | Award | Mar 12, 2026 | $0.00 | 1.0M | $0.00 | 1.0M |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Sell | Mar 03, 2026 | $1,512.68 | 749 | $2.02 | 68,028 |
O'Neill Gilmore Neil CEO | Sell | Mar 03, 2026 | $10,894.26 | 5,394 | $2.02 | 263,693 |
Parison Amy SVP, Chief Financial Officer | Sell | Mar 03, 2026 | $957.48 | 474 | $2.02 | 15,434 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Sell | Sep 03, 2025 | $1,843.23 | 710 | $2.60 | 69,490 |
Parison Amy SVP, Chief Financial Officer | Sell | Sep 03, 2025 | $1,189.01 | 458 | $2.60 | 16,369 |
O'Neill Gilmore Neil CEO | Sell | Sep 03, 2025 | $14,517.39 | 5,592 | $2.60 | 274,690 |
Parison Amy SVP, Chief Financial Officer | Sell | Aug 07, 2025 | $1,751.82 | 679 | $2.58 | 16,827 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Sell | Jul 31, 2025 | $12,756.92 | 5,121 | $2.49 | 64,398 |
Hopfield Jessica | Award | Jun 06, 2025 | $0.00 | 37,500 | $0.00 | 37,500 |
Connaughton Bernadette | Award | Jun 06, 2025 | $0.00 | 37,500 | $0.00 | 37,500 |
Levy Elliott M. | Award | Jun 06, 2025 | $0.00 | 37,500 | $0.00 | 37,500 |
Scadden David | Award | Jun 06, 2025 | $0.00 | 37,500 | $0.00 | 37,500 |
O'Neill Gilmore Neil CEO | Sell | Jun 03, 2025 | $26,195.57 | 15,192 | $1.72 | 280,282 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Sell | Jun 03, 2025 | $1,251.84 | 726 | $1.72 | 69,519 |
Parison Amy SVP, Chief Financial Officer | Sell | Jun 03, 2025 | $768.90 | 446 | $1.72 | 17,506 |
Parison Amy SVP, Chief Financial Officer | Award | Apr 08, 2025 | $0.00 | 34,672 | $0.00 | 34,672 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Award | Mar 08, 2025 | $0.00 | 275,100 | $0.00 | 275,100 |
Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Award | Mar 08, 2025 | $0.00 | 275,100 | $0.00 | 275,100 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Award | Mar 08, 2025 | $0.00 | 70,000 | $0.00 | 70,000 |
Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Award | Mar 08, 2025 | $0.00 | 70,000 | $0.00 | 70,000 |
O'Neill Gilmore Neil CEO | Award | Mar 08, 2025 | $0.00 | 828,000 | $0.00 | 828,000 |
O'Neill Gilmore Neil CEO | Award | Mar 08, 2025 | $0.00 | 175,000 | $0.00 | 175,000 |
O'Neill Gilmore Neil CEO | Sell | Mar 04, 2025 | $28,452.36 | 16,632 | $1.71 | 295,474 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Sell | Mar 04, 2025 | $4,945.63 | 2,891 | $1.71 | 70,245 |
Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Sell | Mar 04, 2025 | $7,029.68 | 4,109 | $1.71 | 112,720 |
Mei Baisong EVP, CHIEF MEDICAL OFFICER | Sell | Dec 03, 2024 | $1,123.77 | 541 | $2.08 | 133,354 |
O'Neill Gilmore Neil CEO | Sell | Dec 03, 2024 | $3,361.23 | 1,618 | $2.08 | 312,106 |